Mechanism of Action animation video

Watch the Infuse Animation

Infuse Healthcare Professionals

Healthcare Providers

INFUSE® Bone Graft is recombinant human bone morphogenetic protein-2(rhBMP-2) applied to an absorbable collagen sponge carrier(ACS). One of the functions of the protein is to stimulate natural bone formation. Overall, bone morphogenetic protein technology has a lengthy history of extensive research and study dating back more than 50 years.

INFUSE® Bone Graft was approved by the U.S. Food & Drug Administration in 2002 for use in Anterior Lumbar Interbody Fusion spine surgical procedures. Additional approvals were received in 2004 and 2007 for trauma and oral-maxillofacial (OMF) indications, respectively.

In 2008, INFUSE® Bone Graft received the coveted Prix Galien Award. The distinguished award recognizes those scientific technologies that have revolutionized their field and significantly impacted the practice of science and medicine.

Review more information about INFUSE® Bone Graft

Icon Alert Important Safety Information - Spine
Icon Alert Important Safety Information - Trauma
Icon Alert Important Safety Information - OMF